Skip to main content

Pharmacopeial Forum Table of Contents

View the current Pharmacopeial Forum (PF) Table of Contents. Forolder PF tables of contents, visit our archive.

Select from the below links to access PF content. A free resource, PF visitors mustcreate a user name and password.

PF 47(4) Table of Contents Publish date: [Jul 1, 2021]

Proposed Interim Revision Announcements

USP Monographs

Ipratropium Bromide Inhalation Solution 1-Jan-2022

Orlistat 1-Jan-2022

Orlistat Capsules 1-Jan-2022

Tetracycline 1-Jan-2022

Tetracycline Hydrochloride 1-Jan-2022

Tetracycline Hydrochloride Capsules 1-Jan-2022

In-Process Revision

General Tests and Assays Chapters

<5> Inhalation and Nasal Drug Products - General Information and Product Quality Tests (USPNF 2022 ISSUE 3)

<87> Biological Reactivity Tests, In Vitro (USPNF 2022 ISSUE 3)

<88> Biological Reactivity Tests, In Vivo (USPNF 2022 ISSUE 3)

<126> Somatropin Bioidentity Tests (USPNF 2022 ISSUE 3)

<857> Ultraviolet-Visible Spectroscopy (USPNF 2022 ISSUE 3)

General Information Chapters

<1031> The Biocompatibility of Materials Used in Drug Containers, Medical Devices, and Implants (USPNF 2022 ISSUE 3)

<1095> Batch Release Testing for Ensuring Compliance with Uniformity of Dosage Units [NEW] (USPNF 2022 ISSUE 3)

<1099> Limit on Number of Large Deviations When Assessing Content Uniformity in Large Samples (USPNF 2022 ISSUE 3)

<1857> Ultraviolet-Visible Spectroscopy - Theory and Practice (USPNF 2022 ISSUE 3)

Reagents, Indicators and Solutions

Reagent Specifications

Cadmium Acetate (USPNF 2022 ISSUE 3)

Fetal Bovine Serum, Heat Inactivated [NEW] (USPNF 2022 ISSUE 3)

Fischer's Medium [NEW] (USPNF 2022 ISSUE 3)

Horse Serum, Heat Inactivated [NEW] (USPNF 2022 ISSUE 3)

Nb2-11 Cell Line [NEW] (USPNF 2022 ISSUE 3)

Silica Gel-Impregnated Glass Microfiber Sheet (USPNF 2022 ISSUE 3)

Volumetric Solutions

0.1 N Tetrabutylammonium Hydroxide VS (USPNF 2022 ISSUE 3)

0.1 N Tetrabutylammonium Hydroxide in Methanol/Isopropyl Alcohol VS (USPNF 2022 ISSUE 3)

0.1 M Tetramethylammonium Bromide VS (USPNF 2022 ISSUE 3)

0.1 M Tetramethylammonium Chloride VS (USPNF 2022 ISSUE 3)

0.05 M Zinc Sulfate VS (USPNF 2022 ISSUE 3)

0.1 M Zinc Sulfate VS (USPNF 2022 ISSUE 3)

0.02 M Zinc Sulfate VS (USPNF 2022 ISSUE 3)

Chromatographic Columns

L109 (USPNF 2022 ISSUE 3)

L128 [NEW] (USPNF 2022 ISSUE 3)

Description and Solubility

Description and Solubility (USPNF 2022 ISSUE 3)

USP Monographs

Albuterol Tablets (USPNF 2022 ISSUE 3)

Atomoxetine Hydrochloride (USPNF 2022 ISSUE 3)

Betamethasone Valerate (USPNF 2022 ISSUE 3)

Bumetanide (USPNF 2022 ISSUE 3)

Bumetanide Injection (USPNF 2022 ISSUE 3)

Bumetanide Tablets (USPNF 2022 ISSUE 3)

Candesartan Cilexetil (USPNF 2022 ISSUE 3)

Candesartan Cilexetil Tablets (USPNF 2022 ISSUE 3)

Candesartan Cilexetil and Hydrochlorothiazide Tablets (USPNF 2022 ISSUE 3)

Cevimeline Hydrochloride [NEW] (USPNF 2022 ISSUE 3)

Colistin Sulfate (USPNF 2022 ISSUE 3)

Dapagliflozin Propanediol [NEW] (USPNF 2022 ISSUE 3)

Darunavir [NEW] (USPNF 2022 ISSUE 3)

Darunavir Tablets [NEW] (USPNF 2022 ISSUE 3)

Dopamine Hydrochloride and Dextrose Injection (USPNF 2022 ISSUE 3)

Emedastine Ophthalmic Solution (USPNF 2022 ISSUE 3)

Emedastine Difumarate (USPNF 2022 ISSUE 3)

Erythromycin Ethylsuccinate Injection (USPNF 2022 ISSUE 3)

Erythromycin Ethylsuccinate Oral Suspension (USPNF 2022 ISSUE 3)

Isosorbide Mononitrate Tablets (USPNF 2022 ISSUE 3)

Liotrix Tablets (USPNF 2022 ISSUE 3)

Menthol (USPNF 2022 ISSUE 3)

Methadone Hydrochloride Tablets (USPNF 2022 ISSUE 3)

Molindone Hydrochloride (USPNF 2022 ISSUE 3)

Naproxen (USPNF 2022 ISSUE 3)

Naproxen Sodium (USPNF 2022 ISSUE 3)

Neomycin Sulfate and Dexamethasone Sodium Phosphate Cream (USPNF 2022 ISSUE 3)

Neomycin Sulfate and Dexamethasone Sodium Phosphate Ophthalmic Solution (USPNF 2022 ISSUE 3)

Neomycin Sulfate and Flurandrenolide Cream (USPNF 2022 ISSUE 3)

Neomycin Sulfate and Flurandrenolide Lotion (USPNF 2022 ISSUE 3)

Neomycin Sulfate and Hydrocortisone Acetate Cream (USPNF 2022 ISSUE 3)

Neomycin Sulfate and Hydrocortisone Acetate Lotion (USPNF 2022 ISSUE 3)

Neomycin and Polymyxin B Sulfates Cream (USPNF 2022 ISSUE 3)

Neomycin and Polymyxin B Sulfates and Gramicidin Cream (USPNF 2022 ISSUE 3)

Neomycin and Polymyxin B Sulfates, Gramicidin, and Hydrocortisone Acetate Cream (USPNF 2022 ISSUE 3)

Neomycin and Polymyxin B Sulfates and Lidocaine Cream (USPNF 2022 ISSUE 3)

Neomycin and Polymyxin B Sulfates and Prednisolone Acetate Ophthalmic Suspension (USPNF 2022 ISSUE 3)

Pamidronate Disodium for Injection (USPNF 2022 ISSUE 3)

Rosuvastatin Calcium (USPNF 2022 ISSUE 3)

Rosuvastatin Tablets (USPNF 2022 ISSUE 3)

Saquinavir Capsules (USPNF 2022 ISSUE 3)

Silver Nitrate (USPNF 2022 ISSUE 3)

Sulbactam Sodium (USPNF 2022 ISSUE 3)

Timolol Maleate Ophthalmic Solution (USPNF 2022 ISSUE 3)

Triazolam Tablets (USPNF 2022 ISSUE 3)

Valganciclovir Hydrochloride (USPNF 2022 ISSUE 3)

NF Monographs

Alginic Acid (USPNF 2022 ISSUE 3)

Potassium Alginate (USPNF 2022 ISSUE 3)

Sodium Alginate (USPNF 2022 ISSUE 3)

Stimuli to The Revision Process

Measurement of the Protective Properties of Amber Glass Containers [NEW] (USPNF 2022 ISSUE 3)